Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Neal Dingmann Bullish on Civitas Resources with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Renewable energy
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Neal Dingmann is bullish on Civitas Resources (NYSE:CIVI), maintaining a Buy rating and increasing the price target to $110 from $107 as of March 4, 2024. Dingmann’s optimistic view on the company’s performance is evident in this latest update.

With a success rate of 54.96% and an average return of -91.4% on 56 stocks covered, Neal Dingmann, known for his Buy recommendations, continues to demonstrate his expertise in the field. His stock forecast success ratio stands at 58.38%, highlighting his knack for identifying potential winners in the market.

CIVI Stock Shows Strong Performance Near 200-Day Moving Average on March 4, 2024

On March 4, 2024, CIVI stock showed positive momentum as it traded near its 200-day simple moving average. The price of CIVI shares increased by $2.13 since the market last closed, representing a 3.10% rise. The stock closed at $70.81, indicating a strong performance for the day.

Trading in the middle of its 52-week range suggests that CIVI stock has been relatively stable over the past year. Being near its 200-day simple moving average indicates that the stock’s long-term trend is also stable.

The 3.10% increase in CIVI’s share price on March 4th shows that investors were optimistic about the company’s prospects. This rise could be attributed to positive news about the company, strong financial performance, or overall market trends.

Investors may have been encouraged by CIVI’s ability to maintain its position near its 200-day moving average, indicating stability in the stock’s performance. This can provide reassurance to investors looking for consistency in their investments.

Overall, CIVI stock showed positive momentum on March 4, 2024, with a significant increase in its share price. Investors will likely be keeping a close eye on the stock’s performance in the coming days to see if this positive trend continues.

CIVI Stock Reports Mixed Performance with Decline in Revenue and Net Income

On March 4, 2024, CIVI stock experienced a mixed performance as the company reported its financial results. According to data from CNN Money, CIVI’s total revenue for the past year was $3.48 billion, which represented a decrease of 8.23% compared to the previous year. In the fourth quarter, the company’s total revenue was $1.13 billion, which remained flat compared to the previous quarter.

Similarly, CIVI’s net income for the past year was $784.29 million, reflecting a decrease of 37.16% compared to the previous year. In the fourth quarter, the company’s net income was $302.87 million, which also remained flat compared to the previous quarter.

Earnings per share (EPS) for CIVI were $9.02 for the past year, marking a decrease of 38.16% compared to the previous year. In the fourth quarter, the company’s EPS was $3.20, which held flat compared to the previous quarter.

Overall, CIVI’s financial performance on March 4, 2024, showed a decline in total revenue, net income, and earnings per share compared to the previous year. However, the company managed to maintain its financial results flat since the previous quarter.

Tags: CIVI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Commercial

Analyst Perspectives on Everbridges Price Target

Finance_ Chart up

Vistra Receives Positive Outlook and Price Target Increase from BMO Capital Markets

Airlines Markets and money (1)

JetBlue and Spirit Airlines Cancel Merger Agreement JetBlue to Focus on Profitability

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com